Bessemer Group
MDCO

Bessemer Group’s Medicines Co MDCO Stock Holding History

Bessemer Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27
Closed -$2K – 1780
2019
Q4 		$2K Hold
27
– – ﹤0.01% 1579
2019
Q3 		$1K Buy
+27
New +$1.08K ﹤0.01% 1713
2017
Q1 		– Sell
-69
Closed -$2K – 1985
2016
Q4 		$2K Buy
+69
New +$2.45K ﹤0.01% 1876

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bessemer Group's MDCO Position: Q1 2020 in Review

Bessemer Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 27 shares — an estimated $2K sold.

Bessemer Group first reported a position in MDCO in Q4 2016 and held it in 3 quarters. The position peaked at $2K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Bessemer Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Bessemer Group sold 27 Medicines Co shares in Q1 2020, an estimated $2K.
  • Bessemer Group first reported a position in Medicines Co in Q4 2016 and held it in 3 quarters.
  • Bessemer Group's Medicines Co position peaked at $2K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Bessemer Group's 13F filing for Q1 2020, filed 30 Apr 2020.